Roncucci
Gabrio Roncucci, Colle Val D'Elsa IT
Patent application number | Description | Published |
---|---|---|
20090130049 | Self-Sterilizing Products - Self-sterilising products, and in particular novel products comprising phthalocyanine derivatives bound to polymers, a process for the preparation of said products and their use for preparing self-sterilising industrial and medical articles or devices, are described. | 05-21-2009 |
20090131393 | Process for Preparing Chlorides of Phthalocyanine Derivatives Comprising at Least a Quaternary Ammonium Group - A process is described for preparing chlorides of phthalocyanine derivatives comprising at least a quaternary ammonium group, products useful as photosensitising agents in photodynamic therapy. | 05-21-2009 |
20110112464 | MESO-SUBSTITUTED PORPHYRINS - Meso-substituted porphyrins of general formula (I) | 05-12-2011 |
Gabrio Roncucci, Colle Val D ' Elsa IT
Patent application number | Description | Published |
---|---|---|
20090131392 | PHTALOCYANINE DERIVATIVES, PROCESS FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE - Phthalocyanine derivatives are described having photosensitising characteristics and high solubility in water, useful for photodynamic treatment of bacterial infections, in particular infections generated by Gram-negative bacteria. | 05-21-2009 |
Gabrio Roncucci, Poggibonsi IT
Patent application number | Description | Published |
---|---|---|
20120135972 | PHTHALOCYANINE DERIVATIVE CONSISTING OF A MIXTURE OF 4 ISOMERS - There is described a phthalocyanine derivative of formula (I) consisting of 4 isomers wherein the relative isomer B content is less than or equal to 1% by weight. | 05-31-2012 |
20140163218 | NOVEL PHTHALOCYANINE DERIVATIVES FOR THERAPEUTIC USE - There are described phthalocyanine derivates, the pharmaceutical compositions and the medical devices that contain them, possibly in combination with chelating agents, such as EDTA, useful for treating, by means of photodynamic therapy, diseases characterised by cellular hyperproliferation, microbial infections caused by Gram− bacteria, Gram+ bacteria and fungi, and for treating various types of infected and non-infected ulcers. | 06-12-2014 |